ATF4 and breast carcinoma: NOX4 silencing or antioxidant (NAC or DPI) treatment reduced the enhancement in intracellular ROS, caspase-3 activity, cytotoxicity, and the PERK-ATF4-CHOP signaling pathway in KA-treated breast cancer cells.